Article

I dare to hope

Author(s):

suzanne lindley blog image

It's 8 am on Monday morning and Chloe has crawled into bed next to me. Her breathing is even, her face angelic, and her body curled into a peaceful cocoon. She is making good use of sleeping late on this teacher work day. Our plan is to have lunch in Tyler with Katie and Karlie and then shop. At this moment, all in the world seems right. Actually, these summer months have been overflowing with the good stuff: horseback rides, sunny days, picnics and nature walks, sand castles by the sea, celebrations, new beginnings, family, friends, and fun. Yet, the week ahead will hold remnant moments of what it is like to live fully in spite of advanced colon cancer; to grab each precious second in the shadow of stable tumors. It will be a reminder to be grateful for the research that has kept my tumors in check. Because, alas, scan time has made it's way to my calendar once again. Scanticipation will ensure that the next few days also carry wonder of another kind. Will my tumors have grown? Have they made their way to different organs? Are there more? Will they be larger? What will treatment entail? What's next?It's been hard at times not to think of what is happening sans treatment. At the same time it is liberating to feel good and to be active. The "regular ol' life" is a beautiful reminder of what life was like before chemo, procedures, labs, and cancer. I'm not ready for this amazing break to end in a screeching halt. Realistic thoughts aside, I'm going to dream for the treatment break to continue in a magical blur of stable tumors and good scans. For a few more days, I dare to hope...

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Image of doctor with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.